146 related articles for article (PubMed ID: 35844046)
1. Use and outcomes of hepatitis B virus-positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021.
Ali SE; Vutien P; Bonham CA; Landis C; Kwo P; Esquivel C; Nguyen MH
Liver Transpl; 2023 Jan; 29(1):80-90. PubMed ID: 35844046
[TBL] [Abstract][Full Text] [Related]
2. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
3. Use and Outcomes of Hepatitis B Virus-positive Grafts for Kidney or Heart Transplantation in the United States From 1999 to 2021.
Singal AK; Reddy KR; Nguyen MH; Younossi Z; Kwo P; Kuo YF
Transplantation; 2024 Mar; 108(3):693-702. PubMed ID: 37953470
[TBL] [Abstract][Full Text] [Related]
4. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Holt D; Thomas R; Van Thiel D; Brems JJ
Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
[TBL] [Abstract][Full Text] [Related]
5. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
6. Impact of Donation After Circulatory Death Allografts on Outcomes Following Simultaneous Liver-Kidney Transplant: A Single-Center Experience and Review of the Literature.
Kumar S; Pedersen R; Sahajpal A
Exp Clin Transplant; 2023 Apr; 21(4):299-306. PubMed ID: 37154590
[TBL] [Abstract][Full Text] [Related]
7. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.
Li Z; Hu Z; Xiang J; Zhou J; Yan S; Wu J; Zhou L; Zheng S
Liver Transpl; 2014 Jan; 20(1):35-45. PubMed ID: 24142889
[TBL] [Abstract][Full Text] [Related]
8. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.
Pan JJ; Oh SH; Soldevila-Pico C; Nelson DR; Liu C
Clin Transplant; 2011; 25(1):164-70. PubMed ID: 20156222
[TBL] [Abstract][Full Text] [Related]
10. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients.
Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB;
Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
[TBL] [Abstract][Full Text] [Related]
14. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease.
Yu J; Shi X; Yu H; Wu J; Ma J; Dong S; Lu S; Zheng S; Li L; Xu X; Cao H
J Med Virol; 2022 Jul; 94(7):3338-3348. PubMed ID: 35257389
[TBL] [Abstract][Full Text] [Related]
16. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.
Ballarin R; Cucchetti A; Russo FP; Magistri P; Cescon M; Cillo U; Burra P; Pinna AD; Di Benedetto F
World J Gastroenterol; 2017 Mar; 23(12):2095-2105. PubMed ID: 28405138
[TBL] [Abstract][Full Text] [Related]
17. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.
Haugen CE; Holscher CM; Luo X; Bowring MG; Orandi BJ; Thomas AG; Garonzik-Wang J; Massie AB; Philosophe B; McAdams-DeMarco M; Segev DL
JAMA Surg; 2019 May; 154(5):441-449. PubMed ID: 30758494
[TBL] [Abstract][Full Text] [Related]
20. Infectivity of hepatic allografts with antibodies to hepatitis B virus.
Dodson SF; Issa S; Araya V; Gayowski T; Pinna A; Eghtesad B; Iwatsuki S; Montalvo E; Rakela J; Fung JJ
Transplantation; 1997 Dec; 64(11):1582-4. PubMed ID: 9415560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
